Business Description
Jeil Pharmaceutical Co Ltd
ISIN : KR7271980005
Compare
Compare
Traded in other countries / regions
271980.Korea IPO Date
2017-07-17Description
Jeil Pharmaceutical Co Ltd is engaged in maufacturing and distribution of pharmaceutical products. The company's products include antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, and anticancer drugs.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.46 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | -3.58 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.55 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.7 | |||||
| 3-Year EBITDA Growth Rate | -7.8 | |||||
| 3-Year EPS without NRI Growth Rate | -5.2 | |||||
| 3-Year FCF Growth Rate | 12.7 | |||||
| 3-Year Book Growth Rate | -2.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.99 | |||||
| 9-Day RSI | 21.87 | |||||
| 14-Day RSI | 31.69 | |||||
| 6-1 Month Momentum % | -9.9 | |||||
| 12-1 Month Momentum % | -1.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.11 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 81.03 | |||||
| Days Sales Outstanding | 77 | |||||
| Days Payable | 102.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.36 | |||||
| 3-Year Dividend Growth Rate | -10.6 | |||||
| Forward Dividend Yield % | 0.36 | |||||
| 5-Year Yield-on-Cost % | 0.27 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -7.43 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.61 | |||||
| Operating Margin % | -3.03 | |||||
| Net Margin % | -5.1 | |||||
| FCF Margin % | -1.6 | |||||
| ROE % | -21.81 | |||||
| ROA % | -7.26 | |||||
| ROIC % | -7.24 | |||||
| 3-Year ROIIC % | 23.2 | |||||
| ROC (Joel Greenblatt) % | -19.23 | |||||
| ROCE % | -17.74 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.29 | |||||
| PB Ratio | 1.19 | |||||
| Price-to-Tangible-Book | 1.29 | |||||
| EV-to-EBIT | -7.84 | |||||
| EV-to-EBITDA | -11.83 | |||||
| EV-to-Revenue | 0.35 | |||||
| EV-to-FCF | -21.83 | |||||
| Price-to-Projected-FCF | 2.12 | |||||
| Price-to-Net-Current-Asset-Value | 53.04 | |||||
| Earnings Yield (Greenblatt) % | -12.76 | |||||
| FCF Yield % | -5.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jeil Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 700,468.356 | ||
| EPS (TTM) (â‚©) | -2452 | ||
| Beta | 0.85 | ||
| Volatility % | 16.24 | ||
| 14-Day RSI | 31.69 | ||
| 14-Day ATR (â‚©) | 450.222239 | ||
| 20-Day SMA (â‚©) | 14743.5 | ||
| 12-1 Month Momentum % | -1.65 | ||
| 52-Week Range (â‚©) | 13000 - 19870 | ||
| Shares Outstanding (Mil) | 14.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jeil Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jeil Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jeil Pharmaceutical Co Ltd Frequently Asked Questions
What is Jeil Pharmaceutical Co Ltd(XKRX:271980)'s stock price today?
The current price of XKRX:271980 is â‚©14070.00. The 52 week high of XKRX:271980 is â‚©19870.00 and 52 week low is â‚©13000.00.
When is next earnings date of Jeil Pharmaceutical Co Ltd(XKRX:271980)?
The next earnings date of Jeil Pharmaceutical Co Ltd(XKRX:271980) is .
Does Jeil Pharmaceutical Co Ltd(XKRX:271980) pay dividends? If so, how much?
The Dividend Yield %  of Jeil Pharmaceutical Co Ltd(XKRX:271980) is 0.36% (As of Today), Highest Dividend Payout Ratio of Jeil Pharmaceutical Co Ltd(XKRX:271980) was 0.69. The lowest was 0.12. And the median was 0.29. The  Forward Dividend Yield % of Jeil Pharmaceutical Co Ltd(XKRX:271980) is 0.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers